Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0001144204-19-005042

Options or other derivatives

  • Chief Medical Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wirostko Barbara · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-02-01 Grant or award : show line 1 in the form Stock Option (right to buy) +50,000 $0.48 2029-02-01 50,000 50,000 D
Loading xslF345X03/tv512442_form4.xml…